Search Results 3281-3290 of 26091 for oral
... oral medications -No history of hypersensitivity to olanzapine or megestrol acetate -No COVID-19 infection in the past that, in the opinion of the treating ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...
Another oral antiviral drug for COVID-19, introduced by drugmaker Merck & Co. Inc. in October via a press release, is molnupiravir. This drug is named in ...
... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...
... oral anti-androgen) is ≤ 60 days prior to registration; Please note: baseline PSA and testosterone must be obtained prior to the start of any ADT. PRIOR TO ...
Primary and first recurrence CDIs are typically treated with oral vancomycin or fidaxomicin regimens. Although it has not yet been approved by the Food and Drug ...
Participant did not start insulin at diagnosis but upon investigator review likely needed insulin (significant hyperglycemia that did not respond to oral agents) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.